Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to Crohn's Disease

NCT06997965 is registered in ClinicalTrials.gov with Alimentiv Inc. as lead sponsor.

NCT NCT06997965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06997965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to Crohn's Disease
Lead sponsor
Alimentiv Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
April 20, 2026
Completion date
April 1, 2028
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease